<DOC>
	<DOCNO>NCT01186289</DOCNO>
	<brief_summary>The primary aim prospective , randomize , double-blind interventional clinical trial determine effectiveness high dose atorvastatin therapy reduce post operative cognitive dysfunction ( POCD ) patient undergo cardiac valve surgery . We hypothesize therapy high dose atorvastatin significantly reduce incidence and/or severity POCD .</brief_summary>
	<brief_title>Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Fifty inform consent patient cardiac valve surgery CPB , great 50 year age care one investigator consultants prospectively enrolled oneyear period ( plus oneyear followup ) . Patients history follow disease entity exclude : symptomatic cerebrovascular disease substantial residual deficit , alcohol abuse , psychiatric illness , renal failure ( creatinine &gt; 2.0 ) , hepatic dysfunction ( ALT AST &gt; 1.5 x ULN ) , history allergy myopathy statin therapy , pregnant breastfeed woman comorbidities opinion investigator could limit patient participation . Exclusion criterion design limit confound enhance differentiation deficit relate surgery treatment . Patients unable read thus unable complete neurocognitive testing also exclude . Patients concomitant carotid endarterectomy vascular surgery also exclude provide homogeneous sample comparison .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Neurocognitive Dysfunction</keyword>
</DOC>